OTCMKTS:EVTCY

Evotec (EVTCY) Stock Price, News & Analysis

Evotec logo
$1.56 -0.02 (-1.27%)
As of 11/16/2026

About Evotec Stock (OTCMKTS:EVTCY)

Advanced

Key Stats

Today's Range
$1.56
▼
$1.60
50-Day Range
$1.35
▼
$1.86
52-Week Range
$14.22
▼
$26.57
Volume
45,903 shs
Average Volume
2,407 shs
Market Capitalization
$515.14 million
P/E Ratio
3.80
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Evotec SE is a drug discovery and development company headquartered in Hamburg, Germany. Founded in 1993, the company works with pharmaceutical and biotechnology companies, as well as academic and research organizations, to advance medicines from early research through development.

Evotec provides integrated research services and technology platforms for identifying and developing drug candidates. Its work spans areas including neuroscience, oncology, metabolic disease and infectious disease. Through Just-Evotec Biologics, it also supports the development and manufacture of biologic medicines.

The company serves partners internationally, with operations in Europe and North America. Its business combines fee-for-service research with collaborative and partnership-based drug development.

AI Generated. May Contain Errors.

Receive EVTCY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Evotec and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

EVTCY Stock News Headlines

Evotec SE : Berenberg reiterates its Neutral rating
Top Trader Reveals Stunning Black Friday Deal
Others paid $500 for the Snapback Indicator. This Black Friday, it's available for just $7. Base Camp Trading's Thomas Wood calls it one of the firm's most powerful proprietary trading indicators, and says the company has never run a deal like this before. There are no strings attached, just a steep Black Friday discount on a tool built for traders.tc pixel
Evotec SE : Gets a Neutral rating from Deutsche Bank
Berenberg downgrades Evotec SE to hold from buy
See More Headlines

EVTCY Stock Analysis - Frequently Asked Questions

Evotec's stock was trading at $3.08 at the start of the year. Since then, EVTCY shares have decreased by 49.4% and is now trading at $1.56.

Evotec shares split on Wednesday, October 20th 2021.The 3-1 split was announced on Wednesday, October 20th 2021. The newly minted shares were payable to shareholders after the closing bell on Wednesday, October 20th 2021. An investor that had 100 shares of stock prior to the split would have 300 shares after the split.

Evotec subsidiaries include Central Glass Germany. GmbH, Central Glass Germany, Rigenerand Srl, GlaxoSmithKine's the Verona site, Just-Evotec Biologics, Aptuit, Cyprotex, and more.

Shares of EVTCY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Evotec investors own include Evotec (EVT), Alnylam Pharmaceuticals (ALNY), Exelixis (EXEL), NetEase (NTES), NVIDIA (NVDA), OPKO Health (OPK) and First Majestic Silver (AG).

Company Calendar

Today
11/17/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Life Sciences Tools & Services
Sub-Industry
Life Sciences Tools & Services
Current Symbol
OTCMKTS:EVTCY
CIK
1412558
Employees
4,200
Year Founded
1993

Profitability

EPS (Trailing Twelve Months)
$0.41
Trailing P/E Ratio
3.80
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$7.14 million
Net Margins
20.85%
Pretax Margin
23.90%
Return on Equity
16.02%
Return on Assets
7.81%

Debt

Debt-to-Equity Ratio
0.53
Current Ratio
2.57
Quick Ratio
2.50

Sales & Book Value

Annual Sales
$572.16 million
Price / Sales
0.90
Cash Flow
$0.01 per share
Price / Cash Flow
105.53
Book Value
$2.52 per share
Price / Book
0.62

Miscellaneous

Outstanding Shares
330,221,000
Free Float
N/A
Market Cap
$515.14 million
Optionable
Not Optionable
Beta
0.98

Social Links

Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

This page (OTCMKTS:EVTCY) was last updated on 11/16/2026 by MarketBeat.com Staff.
From Our Partners